<div>A first-in-class antiretroviral drug is enabling previously hard-to-treat HIV patients live to old age.</div> <hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

A first-in-class antiretroviral drug is enabling previously hard-to-treat HIV patients live to old age. Hosted on Acast. See acast.com/privacy for more information.

A first-in-class antiretroviral drug is enabling previously hard-to-treat HIV patients live to old age. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

What's left for drug-resistant patients?

From the journalists at The Medical Republic, here's what's happening in health and medicine. <hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

News

Medicine

Health & Fitness

From the journalists at The Medical Republic, here's what's happening in health and medicine. Hosted on Acast. See acast.com/privacy for more information.

From the journalists at The Medical Republic, here's what's happening in health and medicine. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Share What's left for drug-resistant patients?

Sign up to save your podcasts

What's left for drug-resistant patients?

What's left for drug-resistant patients?

More shows like The Tea Room

Long Covid Podcast